A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning

被引:12
|
作者
Kawahara, Daisuke [1 ]
Murakami, Yuji [1 ]
Tani, Shigeyuki [2 ]
Nagata, Yasushi [1 ,3 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Radiat Oncol, Hiroshima, Japan
[2] Hiroshima Univ, Sch Med, Hiroshima, Japan
[3] Hiroshima High Precis Radiotherapy Canc Ctr, Hiroshima, Japan
来源
BRITISH JOURNAL OF RADIOLOGY | 2022年 / 95卷 / 1135期
关键词
CANCER; CT;
D O I
10.1259/bjr.20210934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To propose deep-learning (DL)-based predictive model for pathological complete response rate for resectable locally advanced esophageal squamous cell carcinoma (SCC) after neoadjuvant chemoradiotherapy (NCRT) with endoscopic images. Methods and Material: This retrospective study analyzed 98 patients with locally advanced esophagus cancer treated by preoperative chemoradiotherapy followed by surgery from 2004 to 2016. The patient data were split into two sets: 72 patients for the training of models and 26 patients for testing of the model. Patients was classified into two groups with the LC (Group I: responder and Group II: non-responder). The scanned images were converted into joint photographic experts group (JPEG) format and resized to 150 Chi 150 pixels. The input image without imaging filter (w/o filter) and with Laplacian, Sobel, and wavelet imaging filters deep-learning model to predict the pathological CR with a convolution neural network (CNN). The accuracy, sensitivity, and specificity, the area under the curve (AUC) of the receiver operating characteristic were evaluated. Results: The average of accuracy for the cross-validation was 0.64 for w/o filter, 0.69 for Laplacian filter, 0.71 for Sobel filter, and 0.81 for wavelet filter, respectively. The average of sensitivity for the cross-validation was 0.80 for w/o filter, 0.81 for Laplacian filter, 0.67 for Sobel filter, and 0.80 for wavelet filter, respectively. The average of specificity for the cross-validation was 0.37 for w/o filter, 0.55 for Laplacian filter, 0.68 for Sobel filter, and 0.81 for wavelet filter, respectively. From the ROC curve, the average AUC for the cross-validation was 0.58 for w/o filter, 0.67 for Laplacian filter, 0.73 for Sobel filter, and 0.83 for wavelet filter, respectively. Conclusions: The current study proposed the improvement the accuracy of the DL-based prediction model with the imaging filters. With the imaging filters, the accuracy was significantly improved. The model can be supported to assist clinical oncologists to have a more accurate expectations of the treatment outcome. Advances in knowledge: The accuracy of the prediction for the local control after radiotherapy can improve with the input image with the imaging filter for deep learning.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
    Chao, Yin-Kai
    Chang, Hsien-Kun
    Tseng, Chen-Kan
    Liu, Yun-Hen
    Wen, Yu-Wen
    DISEASES OF THE ESOPHAGUS, 2017, 30 (02):
  • [22] Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
    Chih-Yi Chen
    Chia-Chin Li
    Chun-Ru Chien
    World Journal of Surgical Oncology, 16
  • [23] Neoadjuvant chemoradiotherapy versus chemotherapy and surgery for patients with locally advanced esophageal squamous cell carcinoma
    Hao, Daxuan
    Li, Xue
    Yang, Yuanyuan
    Zhang, Yougai
    Wu, Xiaoyuan
    Chen, Yongshun
    He, Chunyu
    Wang, Wen
    Liu, Jinsong
    Wang, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [24] Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Saeki, Hiroshi
    Nakashima, Yuichiro
    Zaitsu, Yoko
    Tsuda, Yasuo
    Kasagi, Yuta
    Ando, Koji
    Imamura, Yu
    Ohgaki, Kippei
    Ito, Shuhei
    Kimura, Yasue
    Egashira, Akinori
    Oki, Eiji
    Morita, Masaru
    Maehara, Yoshihiko
    SURGERY TODAY, 2016, 46 (03) : 261 - 267
  • [25] Neoadjuvant chemoradiotherapy versus chemotherapy and surgery for patients with locally advanced esophageal squamous cell carcinoma
    Hao, Daxuan
    Li, Xue
    Yang, Yuanyuan
    Zhang, Yougai
    Wu, Xiaoyuan
    Chen, Yongshun
    Wang, Jianhua
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (02) : 346 - 353
  • [26] Safety of Neoadjuvant Chemoradiotherapy Followed by Surgery for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
    Herbella, Fernando A. M.
    Patti, Marco G.
    JAMA SURGERY, 2021, 156 (05) : 452 - 452
  • [27] Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
    Chen, Chih-Yi
    Li, Chia-Chin
    Chien, Chun-Ru
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [28] Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Hiroshi Saeki
    Yuichiro Nakashima
    Yoko Zaitsu
    Yasuo Tsuda
    Yuta Kasagi
    Koji Ando
    Yu Imamura
    Kippei Ohgaki
    Shuhei Ito
    Yasue Kimura
    Akinori Egashira
    Eiji Oki
    Masaru Morita
    Yoshihiko Maehara
    Surgery Today, 2016, 46 : 261 - 267
  • [29] Neoadjuvant tislelizumab combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Single arm phase II study
    Jin, Peng
    Gao, Yong Sheng
    Fu, Zheng
    Yang, Wen Feng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Yu, Yong-kui
    Meng, Fan-Yu
    Wei, Xiu-feng
    Chen, Xian-kai
    Li, Hao-miao
    Liu, Qi
    Li, Can-jun
    Xie, Hou-nai
    Xu, Lei
    Zhang, Rui-xiang
    Xing, Wenqun
    Li, Yin
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (02):